1. Home
  2. GANX vs CMTL Comparison

GANX vs CMTL Comparison

Compare GANX & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • CMTL
  • Stock Information
  • Founded
  • GANX 2017
  • CMTL 1967
  • Country
  • GANX United States
  • CMTL United States
  • Employees
  • GANX N/A
  • CMTL N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • Sector
  • GANX Health Care
  • CMTL Technology
  • Exchange
  • GANX Nasdaq
  • CMTL Nasdaq
  • Market Cap
  • GANX 69.0M
  • CMTL 64.4M
  • IPO Year
  • GANX 2021
  • CMTL N/A
  • Fundamental
  • Price
  • GANX $1.64
  • CMTL $2.43
  • Analyst Decision
  • GANX Strong Buy
  • CMTL Strong Buy
  • Analyst Count
  • GANX 5
  • CMTL 1
  • Target Price
  • GANX $8.20
  • CMTL $6.00
  • AVG Volume (30 Days)
  • GANX 614.4K
  • CMTL 155.1K
  • Earning Date
  • GANX 11-13-2025
  • CMTL 10-30-2025
  • Dividend Yield
  • GANX N/A
  • CMTL N/A
  • EPS Growth
  • GANX N/A
  • CMTL N/A
  • EPS
  • GANX N/A
  • CMTL N/A
  • Revenue
  • GANX N/A
  • CMTL $495,352,000.00
  • Revenue This Year
  • GANX N/A
  • CMTL N/A
  • Revenue Next Year
  • GANX N/A
  • CMTL N/A
  • P/E Ratio
  • GANX N/A
  • CMTL N/A
  • Revenue Growth
  • GANX N/A
  • CMTL N/A
  • 52 Week Low
  • GANX $1.36
  • CMTL $1.19
  • 52 Week High
  • GANX $3.19
  • CMTL $5.16
  • Technical
  • Relative Strength Index (RSI)
  • GANX 43.33
  • CMTL 63.83
  • Support Level
  • GANX $1.55
  • CMTL $2.19
  • Resistance Level
  • GANX $1.78
  • CMTL $2.37
  • Average True Range (ATR)
  • GANX 0.13
  • CMTL 0.15
  • MACD
  • GANX -0.03
  • CMTL 0.05
  • Stochastic Oscillator
  • GANX 18.00
  • CMTL 83.08

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

Share on Social Networks: